Biolife Solutions (BLFS) Income from Non-Controlling Interests (2014 - 2019)
Biolife Solutions (BLFS) posted quarterly Income from Non-Controlling Interests of $2000.0 for Q1 2019, up 100.83% quarter-over-quarter from -$241638.0 in Q4 2016.
Biolife Solutions (BLFS) Income from Non-Controlling Interests (2014 - 2019) Analysis & Trends
Biolife Solutions (BLFS) has reported Income from Non-Controlling Interests for 4 consecutive years, with $2000.0 the latest figure, recorded in Q1 2019.
- In Q1 2019, Income from Non-Controlling Interests changed N/A year-over-year to $2000.0; the TTM figure through Sep 2019 stood at $2000.0 (changed N/A YoY), while the FY2016 annual figure was -$1.2 million, down 49.2% from the prior year.
- Income from Non-Controlling Interests climbed to $2000.0 in Q1 2019 per BLFS's latest filing, from -$241638.0 in the prior quarter.
- Across five years, Income from Non-Controlling Interests topped out at $2000.0 in Q1 2019 and bottomed at -$363629.0 in Q2 2016.
- Historically, Income from Non-Controlling Interests has averaged -$216151.8 across 3 years, with a median of -$241638.0 in 2016.
- Annual changes were most pronounced in 2015 — Income from Non-Controlling Interests tumbled 239.11% — and 2016, when it gained 14.19%.
- Biolife Solutions' Income from Non-Controlling Interests stood at -$281610.0 in 2015, then climbed by 14.19% to -$241638.0 in 2016, then jumped by 100.83% to $2000.0 in 2019.
- Business Quant data shows BLFS's Income from Non-Controlling Interests at $2000.0 in Q1 2019, -$241638.0 in Q4 2016, and -$296974.0 in Q3 2016.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 6.60 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | - |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 79.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | - |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | - |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | - |
| 10 | Biolife Solutions | 1.82 Bn | 1.73 Bn | 18.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 30, 2019 | 2,000.00 |
| Dec 31, 2016 | -241,638.00 |
| Sep 30, 2016 | -296,974.00 |
| Jun 30, 2016 | -363,629.00 |
| Mar 31, 2016 | -263,685.00 |
| Dec 31, 2015 | -281,610.00 |
| Sep 30, 2015 | -223,031.00 |
| Jun 30, 2015 | -156,016.00 |
| Mar 31, 2015 | -120,783.00 |
| Dec 31, 2014 | -83,045.00 |